Replikin sequence

Replikin sequences are a controversial class of peptide motifs defined by specific structural requirements: a sequence of 7 to 50 amino acids containing at least two lysines and one histidine, with at least one lysine at each end. According to the theory proposed by Samuel Bogoch, the concentration of these motifs, known as the Replikin Count, serves as a predictor for the rate of replication in viruses and cancer cells (Bogoch & Bogoch, 2005, Nature Precedings). Proponents claim that these sequences are essential for rapid growth and can be used to develop synthetic vaccines and inhibitory drugs called Antireplikins (Bogoch et al., 2001, British Journal of Cancer). Despite these claims, the Replikin concept is not recognized by the broader scientific community and is often characterized as pseudoscientific. Critics argue that the motif is so common and loosely defined that it appears by chance in many unrelated proteins, making it an unreliable target for therapeutic intervention (PubMed, PMID: 16103915). There are no FDA-approved therapies or widely accepted clinical trials validating Replikins as a legitimate therapeutic target. Consequently, while they are marketed as a diagnostic and therapeutic platform for diseases like Influenza, SARS, and various cancers, they remain outside the consensus of modern molecular biology.

Other names

Replikin motifReplikin peptideReplikin count

Targeting and neutralizing specific lysine- and histidine-rich motifs to inhibit rapid genomic replication and viral assembly.